Elizabeth E. Evans - Apr 1, 2022 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Operating Officer
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Elizabeth E. Evans
Stock symbol
VCNX
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/4/2022, 04:33 PM
Previous filing
May 21, 2021
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 9.6K Apr 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +20K $0.00 20K Apr 1, 2022 Common Stock 20K $1.29 Direct F5
holding VCNX Stock Option (Right to Buy) 9.61K Apr 1, 2022 Common Stock 9.61K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 8.61K Apr 1, 2022 Common Stock 8.61K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 12.4K Apr 1, 2022 Common Stock 12.4K $3.90 Direct F2
holding VCNX Stock Option (Right to Buy) 10K Apr 1, 2022 Common Stock 10K $3.82 Direct F3
holding VCNX Stock Option (Right to Buy) 8K Apr 1, 2022 Common Stock 8K $2.93 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully exercisable as of the date of this report.
F2 This option has vested with respect to 9,300 shares and the remainder vests on March 15, 2023.
F3 This option has vested with respect to 5,000 shares and the remainder vests in two equal annual installments beginning on April 3, 2023.
F4 This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F5 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.